Search - tctmd.com

Displaying 961 - 980 of 2449

Sort: Relevancy | Date

Presentation TVT 2022

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Presenter: Brian Whisenant

June 08, 2022

Presentation TVT 2022

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Presenter: D. Scott Lim

June 08, 2022

Presentation TVT 2022

Contemporary Outcomes of TMVR With SAPIEN 3/Ultra for Failed Surgical Repairs With Annuloplasty Rings in the US

Presenter: James McCabe

June 08, 2022

Presentation TVT 2022

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

Presenter: Scott Lim

June 08, 2022

Presentation TVT 2022

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Presenter: Paul Sorajja

June 08, 2022

Presentation TVT 2022

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Presenter: Georg Nickenig

June 08, 2022

Presentation TVT 2022

Innovation in TMVr: Lessons Learned From the Surgeons

Presenter: Thomas Modine

June 08, 2022

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Opinion Editor's Corner EuroPCR 2022

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

Shelley Wood

May 12, 2022

Presentation Fellows 2022

Present and Future of Transcatheter Mitral Valve Therapies

Presenter: Michael Rinaldi

May 08, 2022

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

News Daily News

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Yael L. Maxwell

March 09, 2022

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Caitlin E. Cox

March 08, 2022

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

News Daily News

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Caitlin E. Cox

February 22, 2022

News Daily News

Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes

Michael O'Riordan

February 16, 2022

News Conference News STS 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Michael O'Riordan

February 04, 2022

Advertisement

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Contemporary Outcomes of TMVR With SAPIEN 3/Ultra for Failed Surgical Repairs With Annuloplasty Rings in the US

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Innovation in TMVr: Lessons Learned From the Surgeons

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

Present and Future of Transcatheter Mitral Valve Therapies

As TAVI Turns 20, How Has the Heart Team Evolved?

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content